Home
>
National Drug Code (NDC)
>
VESIcare
VESIcare - 51248-151-03 - (solifenacin succinate)
Drug Information of VESIcare
| Product NDC: | 51248-151 |
| Proprietary Name: | VESIcare |
| Non Proprietary Name: | solifenacin succinate |
| Active Ingredient(s): | 10 mg/1 & nbsp; solifenacin succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VESIcare
| Product NDC: | 51248-151 |
| Labeler Name: | Astellas Pharma Technologies, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021518 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050105 |
Package Information of VESIcare
| Package NDC: | 51248-151-03 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (51248-151-03) |
NDC Information of VESIcare
| NDC Code | 51248-151-03 |
| Proprietary Name | VESIcare |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (51248-151-03) |
| Product NDC | 51248-151 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | solifenacin succinate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20050105 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma Technologies, Inc. |
| Substance Name | SOLIFENACIN SUCCINATE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
